Mycophenolate mofetil Completed Phase 3 Trials for Glomerulosclerosis, Focal Segmental Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00135811Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)